We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx 'Cautiously Optimistic' It Will Pass FDA Facility Review
Andrx 'Cautiously Optimistic' It Will Pass FDA Facility Review
October 21, 2005
Andrx plans to meet with the FDA in November to discuss manufacturing issues that prompted the FDA to place the company's drug applications on hold.